Nebula Research & Development’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.21M	Sell	90,406 -25,014	-22%	-$334K	0.1%	334
2025 Q1	$1.18M	Buy	115,420 +43,710	+61%	+$445K	0.11%	316
2024 Q4	$1.14M	Buy	71,710 +58,271	+434%	+$922K	0.13%	255
2024 Q3	$780K	Buy	13,439 +5,185	+63%	+$301K	0.09%	399
2024 Q2	$377K	Buy	+8,254	New	+$377K	0.06%	519